A humanized monoclonal antibody targeting an ectonucleotidase rescues cardiac metabolism and heart function after myocardial infarction
Summary: Myocardial infarction (MI) results in aberrant cardiac metabolism, but no therapeutics have been designed to target cardiac metabolism to enhance heart repair. We engineer a humanized monoclonal antibody against the ectonucleotidase ENPP1 (hENPP1mAb) that targets metabolic crosstalk in the...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2024-11-01
|
| Serija: | Cell Reports Medicine |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2666379124005421 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
